- Joined
- Dec 3, 2017
- Messages
- 26,290
- Reaction score
- 16,771
- Gender
- Male
- Political Leaning
- Progressive
Approximately 10 million American adults with an attention-deficit hyperactivity disorder (ADHD) diagnosis have a new option for treatment without a stimulant’s side effects, thanks to a new FDA approval for Supernus Pharmaceuticals.
Qelbree, Supernus’ once-a-day pill, won FDA approval Friday to treat adults with ADHD. The approval is the first for a nonstimulant ADHD treatment for adults in 20 years, and it follows the med's original FDA nod in children between the ages of 6 and 17 last April.
“Until today, nonstimulant ADHD options for adults have been very limited,” Greg Mattingly, M.D., founding partner of St. Charles Psychiatric Associates, said in a statement. “This approval is positive news and offers a new novel option for the millions of American adults who are trying to find the right treatment to manage their ADHD symptoms.
============================================
This could be of interest to some. Haven't seen it on TV yet, along with all the drugs Big Pharma keeps pushing. The price of patented drugs could come down if they spent less on TV ads.